Erudio Healtherudio.com
Clinical trial · no report yet · Phase 1/Phase 2
NCT04752722
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- NCT04752722 ↗
- Recruiting
- enGene, Inc.
- Focused
We haven't built an HCP commentary report on NCT04752722 (EG-70 in high-risk non-muscle invasive bladder cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT04752722 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 4 |
The trial
ClinicalTrials.gov- Official title
- A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment
- Phase
- Phase 1/Phase 2
- Status
- Recruiting
- Conditions
- Superficial Bladder Cancer; Non-muscle Invasive Bladder Cancer With Carcinoma in Situ; Non-muscle Invasive Bladder Cancer
- Interventions
- EG-70 (phase 1); EG-70 (phase 2) Master Protocol; Surfactant Bladder Pre-Rinse and EG-70 (Substudy)
- Arms
- Phase 1 · Experimental
- Phase 2 · Experimental
- Phase 1 Substudy Surfactant Bladder Rinse · Experimental
- Enrollment
- 350 (estimated)
- Primary outcomes
- Phase 1: Nature, incidence, relatedness, and severity of all AEs and SAEs according to the CTCAE v5.0.
- Phase 2: Percentage of patients with cystoscopic CR at any time, based on exam, urine cytology and appropriate biopsies.
- Phase 2: Nature, incidence, relatedness, and severity of treatment emergent adverse events (as assessed by CTCAE v5.0)
- Sponsor
- enGene, Inc.
- Start
- Apr 22, 2021
- Primary completion
- Apr 30, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT04752722 · updated Aug 7, 2026